(R) -Zevaquenabant
(R) -Zevaquenabant ((R) -MRI-1867) is the enantiomer of Zevaquenabant. Zevaquenabant ((S) -MRI-1867) is a peripherally restricted, orally bioavailable dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS) . It is beneficial in improving chronic kidney disease (CKD) caused by obesity.
Product Specifications
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog